LONG ACTING ERYTHROPOIETINS THAT MAINTAIN TISSUE PROTECTIVE ACTIVITY OF ENDOGENOUS ERYTHROPOIETIN
Details for Australian Patent Application No. 2003273297 (hide)
Event Publications
5 February 2004 Complete Application Filed
Priority application(s): 60/409,020 09.09.02 US
13 May 2004 Application Open to Public Inspection
Published as AU-A-2003273297
14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
25 August 2005 Corrigenda
Applications OPI - Name Index Under the name WARREN PHARMACEUTICALS, INC., Application No. 2003273297, under INID (71) correct the name to read KENNETH S. WARREN INSTITUTE, INC.; WARREN PHARMACEUTICALS, INC.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003273298-Methods, compositions and libraries pertaining PNA dimer and PNA oligomer synthesis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser